International Journal of Cancer Management

Published by: Kowsar

17β-Estradiol Stimulates Generation of Reactive Species Oxygen and Nitric Oxide in Ovarian Adenocarcinoma Cells (OVCAR 3)

Jafar Maleki 1 , Mitra Nourbakhsh 1 , 2 , Mohammad Shabani 1 , * , Mohsen Korani 3 , Seyed Manuchehr Nourazarian 4 , Mohammad Reza Ostadali Dahaghi 5 and Mohamad Hossein Moghadasi 6
Authors Information
1 Department of Biochemistry, Iran University of Medical Sciences, Tehran, IR Iran
2 Metabolic Disorders Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Biochemistry, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Department of Laboratory Sciences, Tabriz University of Medical Sciences, Tabriz, IR Iran
5 Hematology-Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
6 Departement of Laboratory, Labafi Nedjad Hospital, Social Security Organization, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: May 28, 2015, 8 (3); e2332
  • Published Online: May 22, 2015
  • Article Type: Research Article
  • Received: January 3, 2015
  • Revised: January 19, 2015
  • Accepted: February 3, 2015
  • DOI: 10.17795/ijcp2332

To Cite: Maleki J, Nourbakhsh M, Shabani M, Korani M, Nourazarian S M, et al. 17β-Estradiol Stimulates Generation of Reactive Species Oxygen and Nitric Oxide in Ovarian Adenocarcinoma Cells (OVCAR 3), Int J Cancer Manag. 2015 ; 8(3):e2332. doi: 10.17795/ijcp2332.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Cunat S, Hoffmann P, Pujol P. Estrogens and epithelial ovarian cancer. Gynecol Oncol. 2004; 94(1): 25-32[DOI][PubMed]
  • 2. Blomquist CH, Leung BS, Zhang R, Zhu Y, Chang PM. Properties and regulation of 17 beta-hydroxysteroid oxidoreductase of OVCAR-3, CAOV-3, and A431 cells: effects of epidermal growth factor, estradiol, and progesterone. J Cell Biochem. 1995; 59(4): 409-17[DOI][PubMed]
  • 3. Okoh V, Deoraj A, Roy D. Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta. 2011; 1815(1): 115-33[DOI][PubMed]
  • 4. Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 1998; 58(11): 2269-77[PubMed]
  • 5. Blomquist CH, Bonenfant M, McGinley DM, Posalaky Z, Lakatua DJ, Tuli-Puri S, et al. Androgenic and estrogenic 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms. J Steroid Biochem Mol Biol. 2002; 81(4-5): 343-51[PubMed]
  • 6. Nourbakhsh M, Golestani A, Zahrai M, Modarressi MH, Malekpour Z, Karami-Tehrani F. Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells. Mol Cell Endocrinol. 2010; 330(1-2): 10-6[DOI][PubMed]
  • 7. Wehling M, Losel R. Non-genomic steroid hormone effects: membrane or intracellular receptors? J Steroid Biochem Mol Biol. 2006; 102(1-5): 180-3[DOI][PubMed]
  • 8. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta. 2005; 1746(1): 1-17[DOI][PubMed]
  • 9. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr. 2000; (27): 75-93[PubMed]
  • 10. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1): 44-84[DOI][PubMed]
  • 11. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006; 25(4): 695-705[DOI][PubMed]
  • 12. Park SA, Na HK, Kim EH, Cha YN, Surh YJ. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res. 2009; 69(6): 2416-24[DOI][PubMed]
  • 13. Pavlović D, Đorđević V, Kocić G. Cross-talk” between oxidative stress and redox cell signaling. Med Biol. 2002; 2: 131-7
  • 14. Tamanini C, Basini G, Grasselli F, Trelli M. Nitric oxide and the ovary. J Animal Sci. 2003; 81(14 (suppl 2))-7
  • 15. Yucel AA, Gulen S, Dincer S, Yucel AE, Yetkin GI. Comparison of two different applications of the Griess method for nitric oxide measurement. J Exp Integrat Med. 2012; 2(2): 167-71
  • 16. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2): 97-110[DOI][PubMed]
  • 17. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1995; 1271(1): 67-74
  • 18. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999; 31(4): 971-97[DOI][PubMed]
  • 19. Acharya A, Das I, Chandhok D, Saha T. Redox regulation in cancer: a double-edged sword with therapeutic potential. Oxid Med Cell Longev. 2010; 3(1): 23-34[DOI][PubMed]
  • 20. Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005; 2: 38-44[DOI][PubMed]
  • 21. Schewe T. Molecular actions of ebselen--an antiinflammatory antioxidant. Gen Pharmacol. 1995; 26(6): 1153-69[PubMed]
  • 22. Schimmel M, Bauer G. Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts. Oncogene. 2002; 21(38): 5886-96[DOI][PubMed]
  • 23. Liu H, Nishitoh H, Ichijo H, Kyriakis JM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol. 2000; 20(6): 2198-208[PubMed]
  • 24. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim. 2000; 36(10): 657-66[DOI][PubMed]
  • 25. Okoh VO, Felty Q, Parkash J, Poppiti R, Roy D. Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One. 2013; 8(2)[DOI][PubMed]
  • 26. Weiming XU, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res. 2002; 12(5): 311-20
  • 27. Anttila MA, Voutilainen K, Merivalo S, Saarikoski S, Kosma VM. Prognostic significance of iNOS in epithelial ovarian cancer. Gynecol Oncol. 2007; 105(1): 97-103[DOI][PubMed]
  • 28. Cho MM, Ziats NP, Pal D, Utian WH, Gorodeski GI. Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. Am J Physiol. 1999; 276(2 Pt 1)-49[PubMed]
  • 29. Karpuzoglu E, Ahmed SA. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide. 2006; 15(3): 177-86[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments